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Introduction: There is important evidence on the beneficial effects of treatment of cardiovascular 
risk factors in terms of morbidity and mortality, but important challenges remain in motivating 
patients to adhere to their treatment regimen. This study aimed to describe the effectiveness of a 
quality improvement intervention that included information and regular encouragement by email 
or letter on cardiovascular risk factors for patients at high risk for cardiovascular disease.
Methods: This randomized single-blind study included patients of both sexes aged between 45 
and 80 years old who had increased cardiovascular risk. Patients were randomly allocated to either 
a usual care group (UCG) or advanced care group (ACG). Patients in the UCG received regular 
care while patients in the ACG received usual care plus regular information and encouragement 
on cardiovascular risk factors by email or letter. Visits for both groups were planned at 0, 3, 
and 6 months. The outcome measures were blood pressure, weight, body mass index (BMI), 
waist circumference (WC), and smoking status.
Results: Out of 178 eligible patients from one single primary care practice, 55 participated 
in the study, three of whom dropped out. After 6 months, there was a significant decrease in 
mean systolic and diastolic blood pressure in the UCG and ACG (P , 0.05). The decreases 
were already significant after 3 months, except for systolic blood pressure in the UCG. There 
was also a significant increase in the proportion of patients who met the target values for blood 
pressure in the UCG and ACG. There was a nonsignificant decrease of the average weight in 
the ACG, but significantly more patients lost weight in the UCG (P = 0.02). BMI, WC, and 
smoking status did not change in either group.
Conclusion: This study found that there was a significant decrease of systolic and diastolic 
blood pressure in both study groups. Weight, BMI, WC, and smoking did not improve in either 
group. Information on cardiovascular risk factors and encouragement by means of letters or 
email did not provide additional benefits. Thus, effective patient empowerment probably 
requires more behaviorally sophisticated support to increase self-management, self-efficacy, 
and self-esteem in patients.
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Introduction
Cardiovascular diseases can lead to major complications such as myocardial infarction 
and cerebrovascular accident and continue to be the leading cause of mortality in 
Europe.1–5 There is compelling evidence on the effectiveness of preventive interventions 
(eg, interventions to reduce tobacco consumption, obesity, physical inactivity, 
and harmful alcohol use)5,6 but only a limited number of patients at risk reach 
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treatment targets.6–11 Medication is indicated when targets for 
blood pressure and cholesterol are not achieved with lifestyle 
changes.5 There is no consensus in Belgium on the degree 
of responsibility that should be placed on the individual 
in the prevention of chronic illnesses, as this depends on 
cultural views regarding the role of the state and individual 
autonomy. However, there is increasing recognition that 
reduced risk and improved outcomes cannot depend solely on 
the actions of health professionals but are also contingent on 
the individual’s own actions. Most chronic condition care is 
provided by the individual patient themselves. The successful 
management of chronic illnesses requires patients to make 
multiple lifestyle changes as part of an intensive, complex, 
and coordinated therapeutic regimen aimed at reducing the 
risk of complications often associated with the disease. The 
difficulty in creating and sustaining these lifestyle behavior 
changes is a major stumbling block towards achievement 
of the desired therapeutic goal.12 Further, a Belgian study 
demonstrated that many patients were not even aware of 
their cardiovascular risk factors.13
Available evidence supports the fact that family physicians 
are key players in any chronic illness management strategy, 
as they play an essential role in chronic disease prevention, 
identification, and management. They are also key players 
because they are at the frontline and constitute the gateway 
into the health care system. As such, family physicians have 
an essential role to play in influencing and changing patient 
behavior.14 However, a Belgian study showed that a short 
awareness intervention embedded within usual care did not 
result in a reduction of cardiovascular risk in patients over 
a 7-year period.15
There is substantial evidence on the effectiveness of self-
management interventions in patients with chronic illnesses 
on the outcomes of care.16,17 The World Health Organization 
defines self-management as “the activities individuals, 
families and communities undertake with the intention of 
enhancing health, preventing disease and restoring health.”18 
The overall goal of self-management support is for patients 
and their families to understand the relationship between 
behavior, health, and disease and to be able to take appropriate 
actions with the help of the health system. Although there 
is consensus that self-management support involves a 
patient-centered collaborative approach, the concept of 
“self-management” is frequently imprecisely defined and 
understood to capture a broad range of activities including 
patient education for disease complications and management; 
alcohol, food intake, and exercise advice; and lifestyle visits.19 
Patient education and/or promotion of self-management thus 
encompasses many modes of instruction. There is important 
evidence from quality improvement programs that apply 
information and communication technologies (support by 
phone, teleconference, websites, and text messaging) and 
that target adherence to medication regimens and healthy 
lifestyles in different patient groups. These programs have 
demonstrated positive results for both clinical (eg, mortality, 
survival rates, hemoglobin A1c levels, blood pressure) and 
nonclinical parameters (eg, missed appointments, reduction 
in contact with physicians) as well as an overall reduction in 
cardiovascular risk factors.20–23
This study aimed to describe the influence of regular 
information and encouragement by email or letter on 
cardiovascular risk factors in patients at risk for cardiovascular 
disease development. We hypothesized that our interventions 
would cause a significant decrease in cardiovascular risk 
factors in the intervention group compared with the usual 
care group.
Methods
Study population and design
Patients were recruited in a primary care practice in Beersel, 
Belgium. Patients of both sexes aged between 45 and 80 years 
old were eligible to enter the study if they had an increased 
cardiovascular risk (at time of recruitment or projected at 
the age of 65) and if they were smokers, hypertensive, or 
overweight. The cut-off value for blood pressure was 160 
over 90 mmHg and for overweight, a body mass index (BMI) 
of .25. Eligible patients were invited to participate by letter. 
After confirming their willingness to participate, they were 
contacted by phone to arrange an appointment.
We opted for a randomized single-blind design. 
Participants were randomized during their first visit to either 
a usual care group (UCG) or an advanced care group (ACG). 
A minimization technique was applied, taking into account 
age, sex, and blood pressure values and to ensure an equal 
distribution of men and women, young and old patients, and 
patients with mild and severe hypertension.
intervention
Patients in the UCG received usual care whereas, in 
addition to usual care, patients in the ACG received 
information, encouragement, and personal tips sent by 
post or email every 2 weeks for a period of 6 months. In 
the first round, information was provided to ACG patients 
on determinants of cardiovascular risk, how cardiovascular 
risk was estimated, and the implications of cardiovascular 
risk on health and daily life. In the next round, information 
was provided on hypertension, how it evolves, and 
what patients can do about it in terms of adapting their 
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lifestyles. Following this, specific letters/emails were sent 
on cholesterol followed by physical exercise and healthy 
eating. Patients were informed of the risks of obesity and 
sedentary lifestyles and advised about BMI and their own 
individual cardiovascular risk. Finally, information was 
provided on smoking cessation, diabetes, and their own 
blood pressure.
The aim of the intervention was to empower patients. 
Research has shown that patient empowerment directly 
influences the degree to which treatment goals will be 
achieved as well as the level of patient satisfaction.24
Data collection
For each participant, the family physician completed a form 
at the first visit. In addition, a clinical examination was 
performed.
Data were collected on sex, age, personal history, 
smoking status, latest serum values of total cholesterol 
(TC), high-density lipoprotein cholesterol (HDL-C), low 
density lipoprotein cholesterol (LDL-C), triglycerides, 
glucose, hemoglobin A1c, and treatment for diabetes, 
obesity, hypertension, and dyslipidemia. From the clinical 
examination, systolic and diastolic blood pressure, heart 
rate, height, weight, BMI, and waist circumference (WC) 
were recorded.
Participants in both groups returned after 3 and 6 months 
for their smoking status; current treatment for diabetes, 
obesity, hypertension, and dyslipidemia; and systolic and 
diastolic blood pressure, heart rate, weight, BMI, and WC 
to be assessed and details of these to be recorded.
Ethics committee approval  
and informed consent
The Ethics Committee of the University Hospital of the Vrije 
Universiteit Brussel approved the study protocol in April 
2011. Participants were informed about the study’s aim and 
the methods prior to their inclusion. All participants signed 
an informed consent.
Statistical analyses
For the statistical analyses and processing, SPSS® (v 20; IBM, 
Armonk, NY, USA) was used. The chi-square test was used 
to identify differences between the intervention group and 
the control group. Fisher’s exact test was used for subgroups 
with fewer than ten members. The t-test was used to compare 
continuous variables. The level of significance was determined 
at 0.05. The three cardiovascular risk categories were 
determined according to the European Systematic COronary 
Risk Evaluation (SCORE) Risk Charts for Belgium.
Results
Baseline characteristics
In total, 178 patients met the inclusion criteria for the study, 
of whom 57 agreed to participate; 55 patients were included 
during their first visit, 53 returned after 3 months, and 52 
completed the 6-month study (30 men and 22 women). 
The baseline characteristics for the intervention and control 
groups are compared in Table 1. No significant differences 
were observed between the groups.
Lifestyle changes
No single patient in the UCG or ACG ceased smoking and 
no significant changes in body weight were detected in 
either group (Table 2). After 6 months: the average weight 
of participants in both groups showed a slight nonsignificant 
decrease – minus 700 g in the ACG (P = 0.90) and minus 
400 g in the UCG (P = 0.93); 14 participants in the ACG and 
seven participants in the UCG lost at least 1 kg (P = 0.09); 
the average BMI showed a slight decline, but this decrease 
was not significant (P = 0.88 in the ACG and P = 0.92 in the 
UCG); and the average WC decreased by 2.9 cm in the ACG 
and 2.3 cm in the UCG, but the difference was not significant 
(P = 0.54 and P = 0.58, respectively).
Table 1 Baseline patient characteristics, concomitant diseases, 
and medications
Advanced care  
(n = 26)
Usual care  
(n = 26)
P value
Baseline characteristics
Mean age, in years (SD) 62 (10) 63 (9) 0.84
Men, n (%) 17 (65) 13 (50) 0.26
Women, n (%) 9 (35) 13 (50) 0.40*
  Women aged over 50, n (%) 9 (100) 11 (85) 0.68*
TC, in mg/dL (SD) 202 (38) 198 (30) 0.68
HDL-C, in mg/dL (SD) 60 (26) 63 (12) 0.60
TC/HDL-C, in mg/dL (SD) 4.2 (3.1) 3.3 (0.9) 0.16
Concomitant diseases, n (%)
Myocardial infarction 0 (0.0) 1 (3.8) 1.00*
Stroke 2 (7.7) 1 (3.8) 1.00*
TiA 1 (3.8) 2 (7.7) 1.00*
Vascular disease 0 (0.0) 1 (3.8) 1.00*
Diabetes 2 (7.7) 4 (15) 0.66*
Angor 0 (0.0) 0 (0.0) 1.00*
CABg 2 (7.7 ) 1 (3.8) 1.00*
PTCA 1 (3.7) 1 (3.8) 1.00*
Medication at baseline, n (%)
Aspirin 7 (27) 7 (27) 1.00*
Antidiabetic drugs 2 (7.7) 4 (15) 0.66*
Lipid-lowering drugs 12 (46) 9 (35) 0.29*
Antihypertensive drugs 15 (58) 16 (62) 0.78
Note: *Fisher’s exact test was used for subgroups of ,10 members.
Abbreviations: CABg, coronary artery bypass graft; HDL-C, high-density lipoprotein   
cholesterol;  PTCA,  percutaneous  transluminal  coronary  angioplasty;  SD,  standard  deviation;   
TC, total cholesterol; TiA, transient ischemic attack.
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Blood pressure and heart rate
During the course of the study, no significant difference in 
the systolic or diastolic blood pressure was detected between 
the ACG and the UCG (Table 2). In the ACG, we observed 
a significant decrease in systolic blood pressure (12 mmHg 
and 14 mmHg after 3 and 6 months, respectively [P = 0.003 
and P = 0.001, respectively]) (Figure 1). A similar significant 
decrease in systolic blood pressure was also observed in 
the UCG (14 mmHg and 13 mmHg after 3 and 6 months, 
respectively [P = 0.001 in both cases]). In the ACG, we 
observed a significant decrease in diastolic blood pressure 
of 8 mmHg both after 3 and 6 months (P = 0.002 in both 
cases) (Figure 2). Again, there was a significant decrease 
in diastolic blood pressure of 7 mmHg and 8 mmHg after 
3 and 6 months, respectively (P = 0.008 and P = 0.004, 
respectively).
Further, during the course of the study, no significant 
difference in heart rate was detected between the two groups 
and, after 6 months, there was no decrease in heart rate in 
the ACG (P = 0.23) or the UCG (P = 0.72).
Target level attainment
The number of patients in the ACG who attained a systolic 
blood pressure below 140 mmHg (or 130 mmHg for diabetics) 
after 6 months increased from one to twelve (P = 0.001) 
(Table 4). The number of patients with a diastolic blood 
pressure of less than 90 mmHg (or 80 mmHg for diabetics) 
increased from twelve to 23 (P = 0.001). A similar increase 
was noted in the UCG: the proportion of patients attaining the 
target for systolic blood pressure increased from zero to ten 
(P = 0.002) and from eight to 18 for diastolic blood pressure 
(P = 0.01). For systolic blood pressure, this significant increase 
was not seen in the UCG after 3 months (P = 0.24) whereas, in 
the ACG, the increase was already significant after 3 months 
(P = 0.01). For diastolic blood pressure, the differences 
between both groups were already significant after 3 months. 
The number of patients meeting the targets for both systolic 
and diastolic blood pressure increased significantly after 
3 months in the ACG (P = 0.01) but not in the UCG (P = 0.49). 
After 6 months, the number of participants reaching the blood 
pressure targets (diastolic and systolic combined) increased in 
the ACG (P = 0.001) as well as in the UCG (P = 0.002).
The proportion of overweight or obese patients did not 
change over the 6-month study period in either group, while 
the proportion of patients with an increased WC increased 
over the 6-month study period but not significantly (P = 0.15 
and 0.77 in ACG and UCG, respectively).
Risk evaluation
After 6 months, the number of patients at low risk increased 
from 12 to 16 in the ACG (Table 3). However, the increase was 
not significant (P = 0.27). A similar nonsignificant increase 
Table 2 Patient outcome parameters
Advanced care  
(n = 26)
Usual care  
(n = 26)
P value
Smokers, n (%)
0 months 3 (12) 4 (15) 1.00*
3 months 3 (12) 4 (15) 1.00*
6 months 3 (12) 4 (15) 1.00*
Mean weight, kg (SD)
0 months 84.5 (20.4) 80.8 (15.3) 0.46
3 months 83.9 (20.6) 80.3 (16.0) 0.48
6 months 83.8 (21.1) 80.4 (16.1) 0.52
Body mass index, kg/m2 (SD)
0 months 28.4 (5.7) 28.1 (4.2) 0.83
3 months 28.2 (5.9) 28.0 (4.4) 0.94
6 months 28.1 (6.1) 28.0 (4.5) 0.97
Waist circumference, cm (SD)
0 months 102.6 (16.3) 99.6 (14.8) 0.50
3 months 100.8 (16.2) 99.0 (14.9) 0.68
6 months 99.7 (17.0) 97.4 (14.5) 0.59
Systolic blood pressure, mmHg (SD)
0 months 153 (12) 153 (13) 1.00
3 months 141 (14) 142 (15) 0.87
6 months 139 (15) 139 (14) 1.00
Diastolic blood pressure, mmHg (SD)
0 months 85 (8) 88 (10) 0.24
3 months 77 (8) 81 (10) 0.12
6 months 77 (9) 80 (9) 0.24
Heart rate, bpm (SD)
0 months 70 (9) 70 (6) 1.00
3 months 69 (9) 66 (7) 0.19
6 months 67 (8) 69 (11) 0.46
Note: *Fisher’s exact test was used for subgroups of ,10 members.
Abbreviation: SD, standard deviation.
Table 3 Proportion of patients with a low (,5%), moderate 
(5%–10%)  and  high  ($10%)  cardiovascular  risk  Systematic 
COronary Risk Evaluation (SCORE)a at month 0, 3, and 6
Advanced care  
(n = 26)
Usual care  
(n = 26)
P value
SCORE at month 0, n (%)
Low (,5%) 12 (43) 10 (39) 0.57
Moderate (5%–10%) 5 (19) 7 (27) 0.74*
High (.10%) 9 (35) 9 (35) 0.77*
SCORE at month 3, n (%)
Low (,5%) 14 (54) 13 (50) 1.00
Moderate (5%–10%) 5 (19) 8 (31) 0.52*
High (.10%) 7 (27) 5 (19) 0.74*
SCORE at month 6, n (%)
Low (,5%) 16 (62) 12 (46) 0.26
Moderate (5%–10%) 3 (12) 10 (39) 0.06*
High (.10%) 7 (27) 4 (15) 0.49*
Notes: aAccording to the European SCORE Risk Charts for Belgium; *Fisher’s exact 
test was used for subgroups of ,10 members.
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was also observed in the UCG (P = 0.57). Similarly, in the 
moderate and high-risk groups, no significant changes were 
apparent after 3 and 6 months.
In the subgroup of patients with initial low cardiovascular 
risk, there was a significant increase in the number of 
patients in the ACG who met the targets for systolic blood 
pressure after 3 and 6 months (P = 0.002 and P = 0.001, 
respectively) and for diastolic blood pressure after 
6 months (P = 0.02). For the endpoint of combined systolic 
and diastolic blood pressure targets a similar increase was 
observed after 3 and 6 months (P = 0.002 and P = 0.001). 
For the patients in the UCG, similar observations were 
made after 6 months: there was a significant increase in 
the number of patients with initial low cardiovascular 
risk who met the target of systolic (P = 0.001), diastolic 
(P = 0.02), and combined systolic and diastolic blood 
pressure (P = 0.001).
In the subgroup of patients with initial moderate 
cardiovascular risk, the number in the ACG who met the 
targets for systolic blood pressure had not changed after 
6 months (P = 1.00). The same observation was made in 
the UCG. The number of patients who met the targets for 
diastolic blood pressure did not increase significantly after 
6 months in the ACG (P = 0.20) or the UCG (P = 0.10). 
Similar observations were made for the combined systolic 
and diastolic blood pressure in both groups.
In the subgroup of patients with initial high cardiovascular 
risk, no significant changes were observed after 3 and 
6 months in the ACG or the UCG.
Discussion
A total of 52 patients participated in this study and the 
drop-out rate for woman was greater than that for men. As 
a result, the ACG comprised fewer women, even though 
the participants were minimized by sex at the start of the 
study.
SCORE risks were determined at months 0 and 6 using 
the most recent values of TC and HDL-C. Between these 
times, no additional TC or HDL-C measurements could be 
performed. The SCORE risk was therefore calculated under 
the assumption that patients’ lipid profiles had not changed 
over the course of these 6 months. However, it is reasonable 
to assume that lipid levels decreased during the study period, 
but, for local ethical and practical reasons, no new blood 
samples were taken.
Weight loss
We noticed a decrease in body weight in the ACG as well 
as in the UCG, but this decrease was too small to be 
statistically significant. This finding is not in line with other 
studies reporting that information and encouragement have 
a significant effect on body weight loss.
For example, a study in Baltimore, Maryland, USA 
showed that incentives and coaching through a study-specific 
website significantly improved weight loss in the intervention 
groups compared with the control group.22 Participants in that 
study had on average a much higher start weight than in our 
study and the trial duration was much longer (24 months) 
than ours, giving it higher power.
Another study comparing the influence of the Weight 
Watchers program with usual care showed significantly 
higher weight loss in the Weight Watchers group.19 The 
average start weight was approximately the same as 
in our study, but, again, the study duration was longer 
(12 months) – this may reveal an important weakness in 
our study design. Further, the intervention of the Weight 
Watchers program is also substantially different from our 
intervention.
A Dutch study compared the influence of information on 
lifestyle changes by telephone, email, or lifestyle brochures 
Table 4 Blood pressure, body mass index, and waist circumference 
target level attainment at month 0, 3, and 6
Advanced care  
(n = 26)
Usual care  
(n = 26)
P value
Systolic blood pressure , 140 mmHg (130 mmHg for diabetics), n (%)
  Month 0 1 (4) 0 (0) 1.00*
  Month 3 9 (35) 3 (12) 0.10*
  Month 6 12 (46) 10 (39) 0.57
Diastolic blood pressure , 90 mmHg (80 mmHg for diabetics), n (%)
  Month 0 12 (46) 8 (31) 0.39*
  Month 3 19 (73) 18 (69) 0.76
  Month 6 23 (89) 18 (69) 0.09
Blood pressure , 140/90 mmHg (130/80 mmHg for diabetics), n (%)
  Month 0 1 (4) 0 (0) 1.00*
  Month 3 9 (35) 2 (8) 0.05*
  Month 6 12 (46) 9 (35) 0.57*
Body mass index , 25 m/kg, n (%)
  Month 0 6 (23) 7 (27) 1.00*
  Month 3 7 (27) 7 (27) 0.75*
  Month 6 7 (27) 9 (35) 0.76*
Body mass index , 30 m/kg, n (%)
  Month 0 17 (65) 16 (62) 0.77
  Month 3 17 (65) 16 (62) 0.77
  Month 6 17 (65) 16 (62) 0.77
Waist circumference , 102 cm for men or , 88 cm for women, n (%)
  Month 0 7 (27) 9 (35) 0.76*
  Month 3 10 (39) 10 (39) 1.00
  Month 6 12 (46) 10 (39) 0.78
Note: *Fisher’s exact test was used for subgroups of ,10 members.
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(control group).25 Weight decreased in all three groups but 
a lifestyle modification program with a maximum of ten 
consultations over 6 months favored the average weight 
decrease by 1.6 kg in the telephone group and by 1.1 kg in 
the email group.
BMi
Only one patient in the ACG and two in the UCG were 
able to reduce their BMI to below the 25 kg/m2 target. This 
result is not surprising, since it has been shown that it is very 
difficult to moderate BMI by lifestyle interventions only.2,13 
A multidimensional approach is needed that addresses 
the multiple determinants of obesity in order to prevent 
diabetes, hypertension, hypercholesterolemia, and arthritis 
that, in turn, result in increased cardiovascular morbidity 
and mortality.3,5
WC
Five ACG participants were able to reduce their WC to 
below the target compared with only one participant in 
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the UCG. Compared with other European studies, the total 
proportion of patients achieving the target in our study is 
remarkably higher.2 The decrease in WC in our study is 
similar to those obtained in a Dutch study.25
Reducing WC may have clinical importance, as it is a 
major cardiovascular risk factor.3 Moreover, abdominal fat 
deposition is an important risk factor for the development of 
diabetes and various cardiovascular diseases.26
Smoking
Throughout the entire study, no patient stopped smoking, 
despite a specific emphasis being placed on smoking 
cessation. A possible explanation is that there were few 
smokers in both study groups. In the participating practice, 
serious efforts had previously been made to encourage 
patients to cease smoking. We did not inquire into the 
motivation of smokers to cease smoking.
This finding contrasts with a Spanish study that showed 
that a self-help program on smoking cessation and a single 
short telephone call increased the success rate.27
Blood pressure
The systolic and diastolic blood pressure decreased in the 
ACG and the UCG. After 6 months, the results were signifi-
cant in both groups, but, in the intervention group, the result 
was already significant after 3 months.
Contrary to the nonsignificant difference between 
the ACG and the UCG, other studies have shown that 
encouragement interventions have positive effects on blood 
pressure among patients at cardiovascular risk. For instance, 
a study in Toronto, Canada showed a significantly higher 
decrease in blood pressure in high-risk patients taking part in 
a twice-weekly telephone conference group compared with 
control-group patients.21 However, in our study, a much larger 
decrease in blood pressure was observed after 6 months. This 
is because our study population was older and had higher 
initial blood pressure.
An important finding of our study is that a decrease of 
systolic and diastolic blood pressure could be noticed after 
6 months in both groups. This can potentially be explained 
by the Hawthorne effect.
Risk evaluation
For some individual participants, there was a shift to lower 
risk, but these shifts were not significant for the entire study 
group. The shifts to a lower risk group were mainly due to 
blood pressure decreases, since smoking status did not change 
and lipid levels were not measured during the study – in 
view of the other results, it is unlikely that lipids would have 
changed during the study period.
It is somewhat surprising that participants with an already 
lower cardiovascular risk were most able to decrease their 
blood pressure. Thus, it seems more difficult to initiate 
lifestyle changes among those with a moderate or high 
cardiovascular risk. This is probably because participants 
at low cardiovascular risk were already making some effort 
to decrease their risk and/or they were more susceptible to 
the interventions.
A Dutch study from 2008 looked at the influence of a 
web-based health risk assessment with tailored health advice 
on cardiovascular risk.28 The study revealed a significant 
decrease in cardiovascular risk for the intervention group. In 
contrast to our study, the risk reduction was mainly observed 
in the group with the highest Framingham risk.
Limitations
There are three limitations to this study. First, there were 
relatively few patients in the ACG and UCG; despite 
minimization, the proportion of female patients was 
eventually lower in the ACG. Second, a larger study group 
and a longer follow-up might have revealed more significant 
findings. Finally, determination of lipid levels at the end of 
the study might have revealed changes in lipid concentrations, 
allowing for more accurate risk estimation.
Conclusion
A significant decrease in mean systolic and diastolic blood 
pressure was observed in the ACG and the UCG. In the ACG, 
results were already significant after 3 months and, in the 
UCG, a significant decrease of blood pressure was observed 
after 6 months. The decrease in blood pressure was mainly 
observed among participants with low cardiovascular risk. 
Smoking status, weight, BMI, and WC did not change in 
either group.
The results of this study demonstrate the need for tai-
lored interventions that encourage in patients increased 
self-management and empowerment, with the aim to reduce 
cardiovascular risk factors over a long period. Effective 
patient empowerment probably requires more behaviorally 
sophisticated support to increase patient self-management, 
self-efficacy, and self-esteem.
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